New Jersey Regulators Deny Curaleaf Cannabis License Renewal

April 15, 2023 · Ganjapreneur

New Jersey cannabis regulators on Thursday declined to renew the license of Curaleaf to grow and sell cannabis for the state’s adult-use market, the New Jersey Monitor reports. Curaleaf is a multistate cannabis company and the biggest player in New Jersey’s cannabis industry.

With the denial, Curaleaf’s adult-use license expires on April 21; it’s unclear what the move means for the company’s medical cannabis patients.

The vote came a month after Curaleaf said it confirmed to state regulators that it was closing one of its cultivation facilities and laying off 40 employees. Cannabis Regulatory Commission (CRC) members on Thursday cited the closure, Curaleaf’s clash with unionization, and the company’s lack of transparency as reasons for rejecting the license renewal.

CRC Chair Dianna Houenou said during Thursday’s meeting that “it’s important for the board to have staff at large to have proper insight and timely notice of major changes to facility operations.”

New Jersey’s adult-use cannabis law also requires licensees to maintain business peace agreements as a condition. The law requires collective bargaining within 200 days after a dispensary first opens if the majority of employees vote to form a union.

During the meeting, Commissioner Krista Nash noted that that provision “is an explicit mandate.”

During the meeting, James Shorris, Curaleaf’s chief compliance officer, touted the company’s investments in the state, high sales to medical and adult-use consumers, and job creation with an emphasis on diversity. He also defended the closure of the Bellmawr cultivation site, citing changes in demand for flower and cost concerns.

Curaleaf has not responded publicly to the license denial.

The board did approve the annual licenses for other dispensaries run by Acreage, Rise, Terrascend, and Verano during the meeting. (Full Story)

In category:Dispensaries
Next Post

First Cannabis ‘Casino’ in US Opens

The Reef opened as a medical marijuana dispensary in 2014 and attracted 500 customers a day. That’s before losing almost all of them four years later when recreational marijuana was legalized in nearby Michigan cities, such as Hazel Park and…
Previous Post

Your Guide to Every Weed Dispensary in Chicago

With 21 weed shops in the city plus another 53 in the surrounding suburbs (the state has over 100 facilities), there's a lot of bud to sort through in the Land of Lincoln. Naturally, we've put together a handy guide to every…
Random Post

Canopy Growth’s boom and bust: A timeline

Canopy Growth Corp. announced Thursday it plans to lay off about a third of the company’s staff – close to 800 people – and close its flagship production facility in a former Hershey chocolate factory in Smiths Falls, Ont. It’s the latest…
Random Post

Zappy Zapolin's Psycheceutical Files Patent, Hopes Ketamine Topical Can Treat PTSD

Lifesciences biotech company Psycheceutical Bioscience  BWVI, of which Benzinga’s advisory council member Zappy Zapolin is Chief Visionary Officer, patented a topical ketamine formulation to treat PTSD. The patent includes related methods using drug delivery technology NeuroDirect. Psycheceutical CEO Chad Harman says NeuroDirect’s topical delivery system…
Random Post

Dodgy science, poor access and high prices: The parallel medical world of medicinal marijuana in America

BURTON, Mich. — Before Jayden Carter turned 9, police were called 126 times to his school, home and other locations to address his violent behavior. “I had ribs out of place, my forehead cut open, black eye,” recalled Amie Carter,…
Random Post

Daily use of marijuana raises risk of heart disease, study finds

Using marijuana every day can raise a person’s risk of coronary artery disease, or CAD, by a third compared with those who never partake, a new study found. “A growing body of evidence suggests that cannabis is not entirely without…